Programs

All Programs

Use the tool below to view all available Medtelligence Series

What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
CME/CE
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
0.25 credits
- Ellie Kelepouris, MD, FACP, FAHA
  Peer
- Stephen J. Greene, MD, FACC, FHFSA
  Peer
0.25 credits
What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?
What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?
CME/CE
What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?
0.50 credits
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
- Antoni Bayés-Genís, MD, PhD, FESC, FHFA
  Peer
- Ovidiu Chioncel, MD, PhD
  Peer
- Marco Metra, MD
  Peer
0.50 credits
Addressing Patient Management in ASCVD Risk Reduction: A Collaborative Approach
Addressing Patient Management in ASCVD Risk Reduction: A Collaborative Approach
CME/CE Broadcast Replay
Addressing Patient Management in ASCVD Risk Reduction: A Collaborative Approach
1.00 credit
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Charles P. Vega, MD
  Peer
1.00 credit
Achieving Success in IgAN & FSGS: Expert Insights on Current and Future Therapies
Achieving Success in IgAN & FSGS: Expert Insights on Current and Future Therapies
Video Library
Achieving Success in IgAN & FSGS: Expert Insights on Current and Future Therapies
- Siân Griffin, MD, PhD
  Peer
- Jürgen Floege, MD
  Peer
- Loreto Gesualdo, MD, FERA
  Peer
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
CME/CE
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
0.25 credits
- Nirav Y. Raval, MD, FACC
  Peer
- Gurusher Panjrath, MD, FACC, FAHA, FHFSA
  Peer
0.25 credits
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
CME/CE
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
0.50 credits
- Thilo Krüger, MD, PhD
  Peer
- Steven Fishbane, MD
  Peer
- Lucio Manenti, MD, PhD
  Peer
0.50 credits
What’s the Consensus on Cardiorenal Protection for CKD in T2D?
What’s the Consensus on Cardiorenal Protection for CKD in T2D?
CME/CE
What’s the Consensus on Cardiorenal Protection for CKD in T2D?
0.50 credits
- Tessa Laubscher, MBChB, CCFP, FCFP
  Peer
- George L. Bakris, MD, FAHA, FASN
  Peer
- Mikhail Kosiborod, MD
  Peer
0.50 credits
Applying Evidence to Practice: What Can We Learn from Recent Clinical Trials of IV Iron Use in HF?
Applying Evidence to Practice: What Can We Learn from Recent Clinical Trials of IV Iron Use in HF?
CME/CE
Applying Evidence to Practice: What Can We Learn from Recent Clinical Trials of IV Iron Use in HF?
0.25 credits
- Piotr Ponikowski, MD, PhD, FESC, FHFA
  Peer
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
  Peer
0.25 credits
Hyperkalemia: Is It Still a Challenge in 2023?
Hyperkalemia: Is It Still a Challenge in 2023?
CME/CE
Hyperkalemia: Is It Still a Challenge in 2023?
0.25 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Patrick Rossignol, MD, PhD
  Peer
0.25 credits
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
CME/CE
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
0.50 credits
- Jonathan Barratt, PhD
  Peer
- Donald E. Kohan, MD, PhD
  Peer
0.50 credits
Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
CME/CE
Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- John P. Boehmer, MD
  Peer
0.25 credits
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
CME/CE
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
0.50 credits
- Mario Cozzolino, MD, PhD
  Peer
- Jan T. Kielstein, MD, FASN, FERA
  Peer
0.50 credits
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
CME/CE
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
0.50 credits
- Adam DeVore, MD
  Peer
- Lauren Barron, MD
  Peer
- Navin Kapur, MD
  Peer
0.50 credits
Heart Failure Grand Rounds: 3 Things You Need to Know About Cardiac Contractility Modulation
Heart Failure Grand Rounds: 3 Things You Need to Know About Cardiac Contractility Modulation
CME/CE
Heart Failure Grand Rounds: 3 Things You Need to Know About Cardiac Contractility Modulation
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- William T. Abraham, MD, FACP, FACC, FAHA, FESC, FRCPE
  Peer
0.25 credits
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
Clinician's Roundtable
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
- Hector O. Chapa, MD, FACOG
  Peer
- Julio M. Jimenez
  Peer
Social Media: A Friend or Foe for Healthcare Professionals?
Social Media: A Friend or Foe for Healthcare Professionals?
Clinician's Roundtable
Social Media: A Friend or Foe for Healthcare Professionals?
- Hector O. Chapa, MD, FACOG
  Peer
- Mikaela Rush, MD FACOG
  Peer

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Popular

Title

NEED HELP?

Contact us

Share on ReachMD

Get a Dose of Medtelligence in Your Inbox and Practice Smarter Medicine